Breast cancer, Cancer research, Cancer, Genetics and Internal medicine are his primary areas of study. The various areas that he examines in his Breast cancer study include BRCA2 Protein, Genotype and Gene expression profiling. His Cancer research study which covers Estrogen that intersects with Tamoxifen.
His Cancer research is multidisciplinary, relying on both Missense mutation, Melanoma and Cytogenetics. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Gynecology and Oncology. His research in Germline mutation intersects with topics in DNA Mutational Analysis and Point mutation.
His main research concerns Breast cancer, Internal medicine, Oncology, Cancer research and Cancer. His study with Breast cancer involves better knowledge in Genetics. His Internal medicine study frequently involves adjacent topics like Endocrinology.
His research integrates issues of Prostate cancer, Disease, Cohort and Hazard ratio in his study of Oncology. His Cancer research study incorporates themes from Gene expression profiling, Carcinogenesis, Tumor suppressor gene, Gene duplication and Tumor progression. His Cancer research incorporates themes from Gynecology and Family history.
Åke Borg mainly focuses on Breast cancer, Internal medicine, Oncology, Genetics and Cancer. Åke Borg interconnects Germline mutation, Computational biology, Prospective cohort study and Cohort in the investigation of issues within Breast cancer. As part of one scientific family, Åke Borg deals mainly with the area of Germline mutation, narrowing it down to issues related to the Germline, and often Somatic cell.
His study in Oncology is interdisciplinary in nature, drawing from both Proportional hazards model, Gynecology, Disease and Hazard ratio. He has researched Cancer in several fields, including Genetic counseling, Cancer research and Family history. His Cancer research research is multidisciplinary, incorporating elements of Cell culture, PI3K/AKT/mTOR pathway, Metastasis and Cell cycle.
His scientific interests lie mostly in Breast cancer, Oncology, Internal medicine, Genetics and Germline mutation. His Breast cancer research includes themes of Ovarian cancer, Allele and Gynecology. The concepts of his Oncology study are interwoven with issues in Cancer, Pancreatic cancer, KRAS and Bioinformatics.
His work is dedicated to discovering how Internal medicine, PALB2 are connected with Fanconi anemia, FANCM and Breast cancer chemotherapy and other disciplines. He has included themes like Nonsense mutation, Point mutation and Germline in his Germline mutation study. As a part of the same scientific study, Åke Borg usually deals with the Somatic cell, concentrating on BRCA2 Protein and frequently concerns with Cancer research, Area under the curve, Polymerase and Breast carcinoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio.
Nature (2013)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
A Antoniou;Pdp Pharoah;S Narod;HA Risch.
American Journal of Human Genetics (2003)
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
D Ford;D F Easton;M Stratton;S Narod.
American Journal of Human Genetics (1998)
Gene-Expression Profiles in Hereditary Breast Cancer
I Hedenfalk;D Duggan;Y Chen;M Radmacher.
The New England Journal of Medicine (2001)
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal;Ludmil B. Alexandrov;David C. Wedge;Peter Van Loo;Peter Van Loo;Peter Van Loo.
Cell (2012)
International network of cancer genome projects
Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
Nature (2010)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal;Serena Nik-Zainal;Helen Davies;Johan Staaf;Manasa Ramakrishna.
Nature (2016)
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
(2020)
The Life History of 21 Breast Cancers
Serena Nik-Zainal;Peter Van Loo;Peter Van Loo;Peter Van Loo;David C. Wedge;Ludmil B. Alexandrov.
Cell (2012)
PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma
Lao H. Saal;Karolina Holm;Matthew Maurer;Lorenzo Memeo.
Cancer Research (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Lund University
Lund University
Institute Curie
University of Helsinki
Lund University
University of Toronto
Cancer Council Victoria
Fondazione IRCCS Istituto Nazionale dei Tumori
University of Cambridge
Sheba Medical Center
Georgia Institute of Technology
University of Wisconsin–Madison
Hong Kong University of Science and Technology
Tampere University
University of Alberta
Tsinghua University
Hunan University
Marine Biological Association of the United Kingdom
University of New Hampshire
Duke University
North Carolina State University
Lancaster University
UCB Pharma (Belgium)
Harvard University
Harvard University
University of Helsinki